Brent Harrington, M.S., is a Director in the Statistics group at Pfizer Inc. Worldwide Reasearch and Development in Pharmaceutical Sciences. He is responsible for providing experimental designs and statistical support to the Drug Development and Analytical Research organizations. This support includes analytical method, and drug product and process development of small molecule projects. Brent is active in the development and promotion of performance based criteria for analytical method development utilizing an analytical target profile. Recently, he has authored or co-authored several journal articles and book chapters on the subject of analytical quality by design. Additionally, he is currently participating in a consortium applying AQbD techniques to a monograph development exercise with the British Pharmacopia. Brent received his M.S. in Statistics from Virginia Tech.